A prospective randomized study of cisplatin versus PEV(cisplatin, etoposide, vinblastine) chemotherapy in advanced non-small cell lung cancer

Lee,  Ki Hyeong; Kang,  Won Ki; Jung,  Joung Soon; Yoon,  Sung Soo; Im,  Young Hyuk; Lee,  Jae Yong; Park,  Young Suk; Suh,  Chang In; Heo,  Dae Seog; Bang,  Yung Jue; Shim,  Young Soo; Kim,  Noe Kyeong

J Korean Cancer Assoc > Volume 24(2); 1992 > Article

Original Article

Journal of the Korean Cancer Association 1992;24(2): 256-267.

A prospective randomized study of cisplatin versus PEV(cisplatin, etoposide, vinblastine) chemotherapy in advanced non-small cell lung cancer

Ki Hyeong Lee, Won Ki Kang, Joung Soon Jung, Sung Soo Yoon, Young Hyuk Im, Jae Yong Lee, Young Suk Park, Chang In Suh, Dae Seog Heo, Yung Jue Bang, Young Soo Shim, Noe Kyeong Kim

ABSTRACT

No abstract available.

TOOLS

PDF Links

Full text via DOI

Download Citation

METRICS

2,302

View

Download

Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer 2019 January;51(1)

ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer 2017 July;49(3)

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer 2016 January;48(1)

The Efficacy and Safety of Platinum/Vinorelbine as More Than Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer 2015 October;47(4)

5-Fluorouracil and Cisplatin ( FP ) Combination Chemotherapy in Advanced Esophageal Cancer 1996 ;28(5)

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers